Christian Schultze-Florey

13PUBLICATIONS
66CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 25, 2026
Real-world experience with tabelecleucel within and beyond the approval label.

Kiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold

|Apr 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

|Sep 23, 2022
Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.

Jessica Schneider, Leonie Kuhlmann, Yankai Xiao

|Aug 18, 2022
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

Georg M N Behrens, Joana Barros-Martins, Anne Cossmann

|Sep 17, 2021
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI.

Christian R Schultze-Florey, Leonie Kuhlmann, Solaiman Raha

Pageof 3